Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure
<p>Abstract</p> <p>Background</p> <p>Levosimendan has pharmacologic and hemodynamic advantages over conventional intravenous inotropic agents. It has been used mainly as a rescue drug in the pediatric intensive care unit or in the operating room. We present the largest...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-10-01
|
| Series: | BMC Anesthesiology |
| Online Access: | http://www.biomedcentral.com/1471-2253/11/18 |